Grameva Ltd
Grameva Ltd (GRAMEVA) last reported results for the quarter ended Jun 2026, with sales of ₹46.97 crore and net profit of ₹0.68 crore. The stock last traded at ₹79.2, a market capitalisation of ₹38 crore, on a P/E of 13.4. Over the past 52 weeks the stock has ranged between ₹45.5 and ₹116. Figures are as of 6 Oct 2026 and are not real time.
Grameva Ltd share price and key metrics
- Current price
- ₹79.2
- Market cap
- ₹38 cr
- Stock P/E
- 13.4
- Book value
- ₹23.4
- ROE
- 31.1%
- ROCE
- 25.9%
- Dividend yield
- 0.00%
- 52w high / low
- 116/45.5
Metrics as of 6 Oct 2026. Not real time.
Track Grameva Ltd
Cruxal reads every Grameva Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Grameva Ltd growth and returns
- 10 Years
- 62%
- 5 Years
- 33%
- 3 Years
- 50%
- TTM
- 224%
- 10 Years
- 65%
- 5 Years
- 80%
- 3 Years
- 161%
- TTM
- 167%
- 10 Years
- 17%
- 5 Years
- 43%
- 3 Years
- 46%
- 1 Year
- 31%
- 10 Years
- 8%
- 5 Years
- 10%
- 3 Years
- 15%
- Last Year
- 31%
Grameva Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹46.97 cr, up 558.8% from ₹7.13 cr a year earlier. Net profit was ₹0.68 cr, up 3.0% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 12.4 | 5.5 | 12.75 | 7.13 | 7.31 | 12.57 | 55.68 | 46.97 |
| Expenses | 12.44 | 5.15 | 12.36 | 6.56 | 7.48 | 12.52 | 51.53 | 45.9 |
| Operating profit | -0.04 | 0.35 | 0.39 | 0.57 | -0.17 | 0.05 | 4.15 | 1.07 |
| OPM % | -0.32% | 6.36% | 3.06% | 7.99% | -2.33% | 0.40% | 7.45% | 2.28% |
| Other income | 0.19 | 0.14 | 0.28 | 0.25 | 0.22 | 0.24 | -0.02 | 0.27 |
| Interest | 0.14 | 0.18 | 0.29 | 0.19 | 0.22 | 0.08 | 0.26 | 0.22 |
| Depreciation | 0.09 | 0.09 | 0.08 | 0.09 | 0.1 | 0.09 | 0.14 | 0.18 |
| Profit before tax | -0.08 | 0.22 | 0.3 | 0.54 | -0.27 | 0.12 | 3.73 | 0.94 |
| Tax % | 0.00% | 27.27% | -10.00% | -20.37% | 111.11% | 16.67% | 29.22% | 27.66% |
| Net profit | -0.08 | 0.16 | 0.32 | 0.66 | -0.57 | 0.09 | 2.63 | 0.68 |
| EPS (₹) | -0.17 | 0.33 | 0.67 | 1.38 | -1.19 | 0.19 | 5.48 | 1.42 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Grameva Ltd annual results
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 10 | 17 | 19 | 20 | 22 | 24 | 37 | 41 | 83 | 123 |
| Operating profit | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 1 | 1 | 5 | 5 |
| OPM % | 0.0% | 3.6% | 2.5% | 3.8% | 1.4% | 2.1% | 0.9% | 3.1% | 2.2% | 6% | 4.2% |
| Net profit | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 3 | 3 |
| EPS (₹) | 0.00 | 0.58 | 1.21 | 1.06 | 0.33 | 0.31 | 0.35 | 0.71 | 1.02 | 6.29 | 5.90 |
TTM is the trailing twelve months to the most recent quarter.
Grameva Ltd balance sheet
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity capital | 3 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 0 | 1 | 2 | 2 | 2 | 2 | 3 | 3 | 3 | 6 |
| Borrowings | 0 | 0 | 3 | 3 | 3 | 4 | 3 | 3 | 9 | 10 |
| Other liabilities | 0 | 2 | 3 | 6 | 7 | 3 | 3 | 6 | 5 | 7 |
| Total liabilities | 3 | 8 | 12 | 16 | 17 | 14 | 14 | 17 | 22 | 28 |
| Fixed assets | 0 | 0 | 2 | 1 | 2 | 2 | 3 | 4 | 4 | 4 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other assets | 3 | 8 | 11 | 15 | 15 | 12 | 10 | 13 | 18 | 18 |
| Total assets | 3 | 8 | 12 | 16 | 17 | 14 | 14 | 17 | 22 | 28 |
As reported by the company. Total assets equal total liabilities by construction.
Grameva Ltd cash flow
| ₹ crore | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 0 | -2 | -2 | 1 | 0 | 0 | 1 | 1 | 2 | -3 |
| Cash from investing | -0 | -0 | -1 | 0 | -1 | 0 | -1 | -1 | -7 | 4 |
| Cash from financing | 0 | 3 | 3 | -1 | 0 | 1 | -1 | -0 | 5 | 0 |
| Net cash flow | -0 | 0 | -0 | 1 | -1 | 1 | -1 | 0 | -0 | 2 |
| Free cash flow | 0 | -2 | -3 | 1 | -1 | 0 | -0 | 0 | -6 | -9 |
| CFO / operating profit | — | -563% | -370% | 177% | 89% | 51% | 482% | 128% | 240% | -48% |
Negative figures are outflows. CFO / operating profit is a ratio, not an amount.
Grameva Ltd operating ratios
| Per year | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % | 0% | 7% | 7% | 10% | 7% | 6% | 5% | 10% | 9% | 26% |
| Debtor days | 122 | 206 | 144 | 154 | 134 | 57 | 65 | 57 | 31 | 60 |
| Inventory days | 9,186 | 46 | 8 | 56 | 75 | 64 | 51 | 42 | 42 | 9 |
| Days payable | 0 | 53 | 47 | 135 | 118 | 29 | 38 | 56 | 44 | 25 |
| Cash conversion cycle | 9,308 | 199 | 105 | 76 | 91 | 92 | 77 | 43 | 29 | 44 |
| Working capital days | 4,715 | 190 | 82 | 73 | 86 | 73 | 72 | 45 | 53 | 11 |
Ratios as computed by the source from the reported statements. Rows a company does not report are omitted.
Grameva Ltd shareholding pattern
Promoters held 33.25% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.01%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 33.25% | 33.25% | 33.25% | 33.25% | 33.25% | 33.25% | 33.25% | 33.25% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% |
| Public | 66.74% | 66.74% | 66.74% | 66.75% | 66.75% | 66.74% | 66.74% | 66.74% |
| No. of shareholders | 1,518 | 1,478 | 1,489 | 1,476 | 1,514 | 1,503 | 1,509 | 1,507 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Grameva Ltd corporate filings
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Company Updatelow impact
Cruxal's analysis: Please find enclosed a copy of the Certificate under Regulation74(5) of the SEBI…
Read the full analysis - Persuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, the "Trading Window" for dealing in the securities of the Company will remain closed for all Designated Employees and ....Insider Trading / SASTlow impact
- Grameva Limited Reports Q1 FY2027 Financial Results with Significant Revenue and Profit GrowthCompany Updatehigh impact
Cruxal's analysis: Grameva Limited (formerly Bangalore Fort Farms Limited) reported strong financial…
Read the full analysis - Grameva Limited Reports Q1 FY27 Financial Results and Announces Significant Credit Facility EnhancementBoard Meetinghigh impact
Cruxal's analysis: Grameva Limited reported Q1 FY27 revenue from operations of 46.97 crore, a significant…
Read the full analysis - Grameva Limited schedules Board Meeting for August 14, 2026, to approve Q1 FY27 financial resultsBoard Meetinglow impact
Cruxal's analysis: Grameva Limited has issued a formal intimation under SEBI Regulation 29 regarding a Board…
Read the full analysis - Grameva Limited appoints M/s. SDP & Associates as Statutory Auditors for a five-year termCompany Updatelow impact
Cruxal's analysis: Grameva Limited has formally appointed M/s. SDP & Associates as its new Statutory…
Read the full analysis - Grameva Limited Announces Successful Passing of All Nine Resolutions at 59th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Grameva Limited has successfully concluded its 59th Annual General Meeting held on August…
Read the full analysis - Grameva Limited Concludes 59th AGM; Seeks Shareholder Approval for Enhanced Borrowing and Investment LimitsAGM/EGMmedium impact
Cruxal's analysis: Grameva Limited (formerly Bangalore Fort Farms Limited) has concluded its 59th Annual…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.